IQVIA™ Real-World Insights Bibliography

Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.
Author(s): Moeremans K1, Hemmett L2, Hjelmgren J3, Allegri G4, Smets E5
Affiliations(s): 1 IMS Health, Brussels, Belgium 2 Tibotec, Buckinghamshire, UK 3 Janssen-Cilag AB, Stockholm, Sweden 4 Janssen-Cilag SpA, Cologno Monzese, Italy 5 Johnson & Johnson Pharmaceutical Services LLC, Mechelen, Belgium
Publication(s):  Pharmacoeconomics, 2010, 28 (Suppl 1): 147-167
Document Type(s): Article,
Countries: Belgium, Italy, Sweden, UK,
C:
Y:
HIV AIDS,
2010
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of etravirine in Sweden in treatment-experienced HIV-1-infected adults with evidence of NNRTI resistance and ≥ 3 PI mutations.
Author(s): Moeremans K1, Hjelmgren J2, Martin S3
Affiliations(s): 1 IMS Health, Brussels, Belgium 2 Janssen-Cilag, Birkeöd, Denmark 3 J&J, Mechelen, Belgium
Publication(s):  12th European Aids Conference, 2009, November 11-14, Cologne, Germany
ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France
Document Type(s): Poster,
Countries: Sweden,
C:
Y:
HIV AIDS,
2009
  L:
A:
English
Cost utility,
  Add to report
 
 
Cost effectiveness of darunavir/ritonavir 600/100mg BID in treatment-experienced, LPV/R-naïve, PI-resistent, HIV-infected adults in the United Kingdom, Belgium, Italy and Sweden.
Author(s): Moeremans K, Hemmett L, Hjelmgren J, Allegri G, Smets E
Affiliations(s): 
Publication(s):  ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Type(s): Oral presentation,
Countries: Belgium, Italy, Sweden, UK,
C:
Y:
HIV AIDS,
2008
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-Effectiveness Analysis of Enfuvirtide (ENF) Added to an Optimized Therapy vs an Optimized Therapy Alone in Patients With HIV/AIDS.
Author(s): Badia X, Lizan L, Magaz S, Alvarez C, Green J, Serrano D.
Affiliations(s): 
Publication(s):  HIV Clinical Trials 2007;8(4):235-45
Document Type(s): Manuscript in preparation,
Countries: Spain,
Click here for the abstract
C:
Y:
HIV AIDS,
2007
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Experienced HIV/AIDS patients in different European healthcare settings
Author(s): Moeremans Karen, Annemans Lieven,; Smets Erik, Wyffels Veronique, Lothgren Mickael , Allegri Gabriele
Affiliations(s): 
Publication(s):  ISPOR 2007 10th Annual European Congress
Document Type(s): 
Countries: Europe,
C:
Y:
HIV AIDS,
2007
  L:
A:
English
  Add to report
 
 
Cost of care for HIV/AIDS in Belgium according to disease stage.
Author(s): Caekelbergh K1, Moeremans K1, Annemans L2, De Roo A3, Clumeck N4, Van Wijngaerden E5, Vandercam B6, Moutschen M7, Smets E8
Affiliations(s): 1 IMS Health, Brussels, Belgium 2 Ghent University, Ghent, Belgium 3 Institute for Tropical Medicine, Antwerp, Belgium 4 St. Pierre University Hospital, Brussels, Belgium 5 University Hospital Leuven, Belgium 6 University Hospital St. Luc, Brussels, Belgium 7 University Hospital Sart Tilman, Liège, Belgium 8 Johnson & Johnson Pharmaceutical Services, Mechelen, Belgium
Publication(s):  11th European AIDS Conference (EACS), 2007, October 24-27, Madrid, Spain
Document Type(s): Oral presentation,
Countries: Belgium,
C:
Y:
HIV AIDS,
2007
  L:
A:
English
Cost of illness,
  Add to report
 
 
Cost-effectiveness of DRV/r in highly treatment-experienced HIV/AIDS patients in different European healthcare settings.
Author(s): Moeremans K, Annemans L, Smets E, Wyffels V, Wilson B, Lothgren M, Allegri G
Affiliations(s): 
Publication(s):  11th European AIDS Conference (EACS), 2007, October 24-27, Madrid, Spain
Document Type(s): Oral presentation,
Countries: Belgium,
C:
Y:
HIV AIDS,
2007
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of Darunavir/r in highly treatment-experienced HIV/AIDS patients in different European healthcare settings.
Author(s): Moeremans K, Annemans L, Smets E, Wyffels V, Lothgren M, Allegri G
Affiliations(s): 
Publication(s):  ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
Document Type(s): Oral presentation,
Countries: Belgium,
C:
Y:
HIV AIDS,
2007
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with HIV.
Author(s): Munakata J, Benner JS, Becker SL, Dezii CM, Hazard EH, Tierce JC.
Affiliations(s): 
Publication(s):  Medical Care 2006;44(10):893-899.
Document Type(s): Manuscript in preparation,
Countries: USA,
C:
Y:
HIV AIDS,
2006
  L:
A:
English
  Add to report
 
 
Evaluation of a HCV Patient Support Program’s Impact on Patient Adherence.
Author(s): M. Hussein, J. S. Benner, D. Lee, and others. Evaluation of a HCV Patient Support Program’s Impact on Patient Adherence. (Oral Presentation). Digestive Disease Week 2006 (DDW 2006). May 20-25, 2006. Los Angeles, CA.
Affiliations(s): 
Publication(s):  Digestive Disease Week 2006 (DDW 2006). May 20-25, 2006. Los Angeles, CA.
Document Type(s): Oral presentation,
Countries: USA,
C:
Y:
HIV AIDS,
2006
  L:
A:
English
  Add to report
 
 
 1 of 2 Next Page Last Page